Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimimed M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Medmom Pharmaceuticals LLP

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimimed M 1mg/500mg Tablet SR

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before initiating treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimimed M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimimed M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimimed M 1mg/500mg Tablet SR whole; do not chew, crush, or divide it. Administer this medication with a meal.

Common Side effects of Glimimed M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimimed M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimimed M 1mg/500mg Extended-Release Tablets should be taken with a meal.

How Glimimed M 1mg/500mg Tablet SR works:

Glimimed M SR tablets (1mg glimepiride/500mg metformin) combine two diabetes medications. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimimed M 1mg/500mg SR tablets with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimimed M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glimimed M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are either elevated or depressed. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Exercise caution when administering Glimimed M 1mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician before use. Glimimed M 1mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimimed M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is unsuitable for those with severe liver disease.

What if you forget to take Glimimed M 1mg/500mg Tablet SR :

Should you forget to take a Glimimed M 1mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glimimed M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimimed M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimimed M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimimed M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimimed M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimimed M 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimimed M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimimed M 1mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimimed M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and may increase the risk of lactic acidosis.
Glimimed M 1mg/500mg Tabl...
78
MRP 95
17% off